You are here: Industry Insights > therapeutics

News List

G1 Therapeutics Appoints Chief Business Officer contractpharma
July 31, 2019
Mark Avagliano to lead the company’s global partnering and corporate development strategy and execution.
Zambon Acquires Sofinnova Partners’ Breath Therapeutics contractpharma
July 26, 2019
Italian pharma company purchases Breath Therapeutics for €500 million, with €140 million up front.
Mallinckrodt, Silence Therapeutics Enter RNAi Alliance contractpharma
July 24, 2019
Aims to develop and commercialize RNAi therapeutics for complement-mediated diseases.
Astellas, Frequency Therapeutics Enter Alliance for Hearing Loss Treatment contractpharma
July 18, 2019
Aims to develop and commercialize Frequency’s candidate, FX-322, for the treatment of sensorineural hearing loss.
Celldex Therapeutics Appoints CMO contractpharma
June 25, 2019
Young brings 30 years of experience leading clinical and cross-functional R&D teams.
CymaBay Therapeutics Reports Results for Seladelpar in NASH contractpharma
June 21, 2019
Results included minimal reductions in liver fat that were not significant when compared to placebo.
PTC Therapeutics Appoints CFO contractpharma
June 04, 2019
Ms. Hill joined the company in November 2013 and was most recently senior vice president and head of Investor Relations.
NIH awards T3D Therapeutics $9m to fund a trial of its lead product pharmaceutical-technology
May 23, 2019
US-based T3D Therapeutics has announced it has received a $9m grant over four years from the US National Institutes of Health (NIH)’s National Institute of Aging to support its Phase II clinical trial of its lead candidate T3D-959 in Alzheimer’s disease.
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla drugs
May 21, 2019
Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla.
Cristal Therapeutics to Present Data at the American Society of Clinical Oncology (ASCO) 2019 Annual Meeting on Lead Clinical Candidate CPC634 in Patients With Solid Tumors b3cnewswire
May 20, 2019
Florence Atrafi, MD, a clinical investigator on the phase 1 NAPOLY study, has received a prestigious ASCO Merit Award in recognition of her abstract that highlights important research findings.

Previous page 1 2 3 4 5 Next page